In the animal experiment on DM II, ACP can significantly improve the hyperglycemia symptoms of DM II mice, reduce blood lipid, reduce liver and kidney injury, and increase the contents of SOD, liver glycogen, and insulin. This evidence concerns the gene SOD1 and Hyperglycemia.